Clinical research临床研究中

Community protocol · VIP

VIP: community information and evidence, clearly separated.

A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.

Also known as: Vasoactive intestinal peptide · Aviptadil

Sources checked: 27 August 2026

重要安全与责任声明

本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。

No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.

Quick context

VIP

影响血管、肠道、肺部及神经信号；相关治疗用途和类似物仍处于临床研究阶段。

Published study protocols are research procedures with inclusion and exclusion criteria. They are not instructions for unsupervised use.

Amounts, timing and cycles

Clinical research

Published study protocols are research procedures with inclusion and exclusion criteria. They are not instructions for unsupervised use.

Amount status

Trials use protocol-bound amounts and escalation; this does not create a safe community dose.

Profile evidence level: clinical.

Timing

Timing is set by each trial protocol and may differ substantially between studies.

No individual recommendation.

Cycle/duration

Duration is study-specific and ends according to protocol; long-term safety may remain unknown.

No individual recommendation.

External community reference available

The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.

Open community source

复配与 U-100 换算

复配计算器

For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.

复配计算器

Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.

Total vial amount (mg)Fluid added (ml)Amount to calculate (µg)

Concentration

3,333.33 µg/ml

Calculated volume

0.06 ml

U-100 units

6 U

Calculated portions per vial

Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.

Mechanism and research questions

Endogenous neuropeptide acting at VPAC receptors

VIP is classified as “Endogenous neuropeptide acting at VPAC receptors”. 影响血管、肠道、肺部及神经信号；相关治疗用途和类似物仍处于临床研究阶段。 This describes the investigated pathway but does not validate a community use, amount, route or combination.

VPAC受体信号传导

这项研究考察结合VPAC受体如何介导对血管、消化和免疫功能的影响,类似于同时触及多个器官系统的信号。在实验室和临床模型中测量血流和炎症标志物。

血管、肺与肠道信号传导

这项研究考察某信号如何同时影响血管、气道组织和消化道,类似于一个调度中心同时向多个部门下达指令。研究人员通常在实验室或临床模型中测量血流、气道功能和肠道活动。

神经内分泌信号传导

这项研究考察神经系统与激素分泌腺体之间如何相互沟通,类似于连接大脑与远端器官的双向电话线路。研究人员通常同时测量血液中的激素水平和神经系统活动标志物。

What communities discuss

These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.

综合健康论坛

人们在此交流使用各类产品后情绪、睡眠和整体感受等更宽泛的健康印象,通常没有结构化的记录。这类笼统印象无法替代有针对性的临床检查。

生物黑客与长寿论坛

用户比较自行组合的肽方案,以期影响衰老过程或能量水平,常常依据血液检测或主观幸福感量表。个人自我实验和营销承诺无法取代对照的长期人体研究。

来源与纯度讨论

人们讨论哪些商家被认为更值得信赖,以及不同批次之间纯度检测结果的差异。这类社区评估基于有限的样本,无法替代对每一批次进行的独立实验室检测。

Adverse effects and risk boundaries

生殖、血管活性或水分调节信号可影响激素轴、血压、心率、液体平衡及妊娠；风险高度取决于途径和适应证。
Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Exclusion groups and professional assessment

妊娠或生育计划、心血管疾病、电解质/液体紊乱及激素敏感性疾病需要针对适应证的医疗监督。
Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

根据目标，可监测生命体征、液体平衡、电解质、生殖激素及明确定义的临床终点。
Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

临床试验中

治疗用途及其类似物仍处于临床研究阶段,尚未获得广泛批准。

Published evidence

该物质目前正在结构化的人体临床试验中进行研究,尚未获得普遍批准。

VIP通过VPAC受体作用于血管、肠道和肺部信号传导,不同于主要调控生殖通路的催产素。

Storage and stability

The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and error sources

U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

临床研究中

处于临床开发阶段，尚不是获批药物。

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Comparisons and related profiles

Combinations / stacks

Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Sources and evidence layers

Primary sources and official registries take priority. The community reference is labelled separately.

Primary/technical sourcePubMed: biomedical literature database
Primary/technical sourceFDA: official drug-label search
Community referenceVIP — Peptide Dosing Protocols

Back to all 64 profiles Open scientific atlas profile